ERBB2 and breast carcinoma: Well recognized molecular subtypes of breast cancer such as hormone receptor negative and ERBB2 over-expressing tumors are known to be associated with reduced survival [27], and it will be necessary to extensively examine methylation markers stratified by commonly used molecular tumor markers.